Natco Pharma informs about press release

02 Jul 2018 Evaluate

Natco Pharma has informed about press release titled, 'NATCO launches fixed dose combination of Sofosbuvir-Daclatasvir drug for Hepatitis C treatment in INDIA'.

The above information is a part of company’s filings submitted to BSE.

Natco Pharma Share Price

991.25 -7.60 (-0.76%)
17-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1530.00
Dr. Reddys Lab 5802.00
Cipla 1399.35
Zydus Lifesciences 1051.90
Lupin 1653.75
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.